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Abstract
Objectives: To investigate whether a combination of demineralized bone matrix
(DBM) and bone marrow mesenchymal stem cells (BMSCs) infected with
adenovirus-mediated- bone morphogenetic protein (Ad-BMP-2) and transforming
growth factor-b3 (Ad-TGF-b3) promotes the repair of the full-thickness cartilage
lesions in pig model.
Methods: BMSCs isolated from pig were cultured and infected with Ad-BMP-2(B
group), Ad-TGF-b3 (T group), Ad-BMP-2 + Ad-TGF-b3(BT group), cells infected
with empty Ad served as a negative group(N group), the expression of the BMP-2
and TGF-b3 were confirmed by immunofluorescence, PCR, and ELISA, the
expression of SOX-9, type II collagen(COL-2A), aggrecan (ACAN) in each group
were evaluated by real-time PCR at 1w, 2w, 3w, respectively. The chondrogenic
differentiation of BMSCs was evaluated by type II collagen at 21d with
immunohistochemical staining. The third-passage BMSCs infected with Ad-BMP-2
and Ad-TGF-b3 were suspended and cultured with DBM for 6 days to construct a
new type of tissue engineering scaffold to repair full-thickness cartilage lesions in
the femur condyles of pig knee, the regenerated tissue was evaluated at 1,2 and 3
months after surgery by gross appearance, H&E, safranin O staining and O’driscoll
score.
Results: Ad-BMP-2 and Ad-TGF-b3 (BT group) infected cells acquired strong type
II collagen staining compared with Ad-BMP-2 (B group) and Ad-TGF-b3 (T group)
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along. The Ad-BMP-2 and Ad-TGF-b3 infected BMSCs adhered and propagated
well in DBM and the new type of tissue engineering scaffold produced hyaline
cartilage morphology containing a stronger type II collagen and safranin O staining,
the O’driscoll score was higher than other groups.
Conclusions: The DBM compound with Ad-BMP-2 and Ad-TGF-b3 infected
BMSCs scaffold has a good biocompatibility and could well induce cartilage
regeneration to repair the defects of joint cartilage. This technology may be
efficiently employed for cartilage lesions repair in vivo.

Introduction
Injuries to articular cartilage can be difficult to effectively treat since self-repair of
the tissue is limited by an inherent low-capacity for natural regeneration [1–3].
This difficulty has prompted the development of numerous therapeutics,
including autologous cartilage transplantation [4] or treatment typical of
abrasions and micro-fractures [5], but neither technique is entirely satisfactory
[6, 7]. One novel approach to these deficits is tissue engineering therapy, which
hinges enhancing the body’s own natural capacity for self-repair by creating an
environment for tissue development and regeneration with the appropriate cell
populations, necessary cellular signals, and suitable scaffolds [8]. However, for
tissues with naturally low-capacities for self repair, such as articular cartilage,
suitable treatments require a method of regrowth of tissue. For these cases, Bone
Mesenchymal Stem Cells (BMSCs) offer potentially revolutionary a fascinating
cell source for regenerative medicine because they can be induced to different cell
types under appropriate conditions [9, 10].
Previous studies demonstrated that several different growth factors, such as
bone morphogenic proteins (BMPs) and transforming growth factors beta (TGFbeta), are capable of inducing the differentiation of mesenchymal cells into
chondrocytes under certain culture conditions [11, 12]. While transforming
growth factor beta3 (TGF-b3) is known to promote the chondrogenic
differentiation of progenitor cells, bone morphogenetic protein 2 (BMP-2) has
also recently emerged as a key regulator of stem cell commitment, playing an
essential role in chondrogenic differentiation [13]. However, each acting alone
does not seem to suitably enhance tissue growth and differentiation; in a recent
study, BMP-2 was found to enhance TGF-b3 mediated chondrogenesis of human
bone marrow or adipose tissue-derived mesenchymal stem cells [14, 15]. This
result suggests that that a combination of BMP-2 and TGF-b3 may be superior to
the standard differentiation method using either TGF-b3 or BMP-2 to promote
BMSCs chondrogenesis.
Though some of these initial studies on BMSCs chronogenesis aided by either
TGF-b3 or BMP-2 have been promising, more wide-spread clinical utility of these
approaches is limited by the short half-lives [16] of the proteins as well as
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prohibitive capital investment requirements [17]. To overcome these obstacles, in
the present study we sought to used the adenovirus-mediated bone morphogenetic protein 2 (Ad-BMP-2) and transforming growth factor beta 3 (Ad-TGF-b3)
that were constructed to infect BMSCs to construct a new type of tissue
engineering scaffold in a Demineralized Bone Matrix(DBM). To assess the ability
of these scaffolds, we tested their effectiveness in repairing full-thickness cartilage
defects in the femoral condyles of dian-nan small ear pig. Gross observation, H&E
and safranin O staining, O’driscoll score were used to assess the defected healing.

Materials and Methods
BMSCs Isolation, Culture, Proliferation, and Identify
BMSCs were isolated from 8-month-old diannan-small-ear pigs (n512). All
experiments were authorized by the Animal Center for Medical Experimentation
at the Kunming Medical University.
Marrow aspirates of pigs from the iliac crest, as described by Pittenger et al,
were washed in Dulbecco’s modified Eagle’s medium Ham’s F-12(DMEM/F-12)
(Gibco BRL, USA) with heparin (approx. 200units/ml final) and centrifuged for
5 min at 900 g. After the supernatant were removed, the washed cells were plated
in culture flasks with DMEM/F-12 supplemented by 10% fetal bovine serum
contained 100 IU/ml penicillin and 100 mg/ml streptomycin at 37 ˚C with 5%
CO2. The medium was replaced every 2 days to remove non-adherent cells and
debris. Cells were harvested at 80–90% confluence with 0.25% trypsin, counted,
and subcultured at 1:2 dilutions in culture flasks. Multidirectional differentiation
and flow cytometric analysis were used to identify the isolated cells. In brief,
isolated cells were differentiated into adipocytes, osteocytes and chondrocytes,
respectively [9, 10]. Third passage BMSCs were cultured in adipogenic or
osteogenic induction medium. adipogenic medium consisting of basic culture
medium supplemented with 10% FBS, 1 mM dexamethasone, 0.5 mM indomethacin, 10 mg/ml insulin and 100 mM 3-isobutyl-1-methylxanthine.
Osteogenic medium consisting of basic culture medium supplemented with
100 nM dexamethasone, 10 mM sodium b-glycerophosphate, 0.05 mM ascorbic
acid. For chondrocyte differentiation, a pellet culture system was used. BMSCs
(passage 3) were trypsinized and seeded at 26105cells/ml in 15 ml polypropylene
tubes, and centrifuged to pellet, cultured at 37 ˚C with 5% CO2 in 500 ml of
chondrogenic medium which consisting of basic culture medium supplemented
with 10% ITS (6.25 mg/ml insulin, 6.25 mg/ml transferrin, 6.25 mg/mL selenious
acid), 1 mM pyruvate, 50 mg/ml ascorbate 2-phosphate, 0.1 mM dexamethasone,
and 8 ng/ml TGF-b1. The medium was replaced every 2 days for 21 days, Oil red
staining, Alizarin Red Staining and Toluidine blue staining were used to evaluate
the adipogenic differentiation, osteogenic differentiation and chondronic
differentiation respectively. Antibodies included CD29, CD44, CD45 (BD
Biosciences Pharmingen, San Jose, CA) were analyzed in the cells of passage 0, 1, 2
on an FACS Calibur flow cytometer (BD Biosciences).
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Preparation of recombinant adenoviral vectors encoding BMP-2
or/and TGF-b3
Ad-BMP-2 and Ad-TGF-b3 respectively containing human BMP-2 and TGF-b3
cDNA were constructed as described previously [18, 19]. In brief, BMP-2 cDNA
and TGF-3 cDNA were amplified by PCR and then subcloned into a pEC3.1(+)
plasmid (the pEC3.1(+) connected with BMP-2 cDNA was reconstructed to
combine with IRES-EGFP)to respectively obtain pEC-GIE 3.1-BMP-2-EGFP and
pEC-GIE 3.1-TGF-b3 plasmids. These were subcloned into pGSadeno vector via
homologous recombination reaction to obtain both Ad-BMP-2 and Ad-TGF-b3.
Ad-BMP-2 was constructed to express human BMP-2 and green fluorescent
protein (GFP) tag, while Ad-TGF-b3 was constructed to not express any
fluorescent tag. To generate high-titer preparations, the recombinant vectors were
amplified in 293 cells and purified over three successive CsCl gradients.

Adenoviral infection and determine the optimal multiplicity of
infection in vitro
Third-passage BMSCs were cultured in 6-well plates at a density of 26105 cells/
well. Solutions of Ad- BMP-2 or Ad-TGF-b3 virus particles at an multiplicity of
infection(MOI) of 0, 10, 20, 50, 100, 200 were premixed with 2 ml DMEM/F12
containing 2% FBS, and 1% penicillin/streptomycin were added to the cell culture
wells. Each day, cell morphology and pathological changes were observed under
light microscopy. Transduction efficiency of Ad-BMP-2 was analyzed 48 hours
post transduction by determining the population of cells with GFP expression
within the total cell population. Since Ad-TGF-b3 had no fluorescent tag
expression, its transfection efficiency was analyzed via flow cytometry. The
optimal multiplicity of infection were determined by transfection efficiency and
cell pathological changes.
(Transfection efficiency and cell pathological changes were showed in Table 1).
An MOI of 20 (Ad- BMP-2) and MOI of 50 (Ad-TGF-b3) were used for the
subsequent experiments.
Third-passage BMSCs were cultured in 6-well plates at a density of 26105 cells/
well. To characterize the effects of the different growth factors, Ad-BMP-2 (n56),
Ad-TGF-b3 (n56), Ad-BMP-2 + Ad-TGF-b3 (n56) were then added to each well
with 2 ml of DMEM/F12 containing 2% FBS to create the test groups (hereafter B
group, T group, and BT group) with cell cultures infected with empty Ad serving
as a negative control (n56; hereafter N group). The medium was replaced every 2
to 3 days, and the culture supernatant were harvested at various time points were
stored at 220 ˚C until further analysis.

Ad-BMP-2 and Ad-TGF-b3 transgene expression in BMSCs
a. Immunofluorescence staining in vitro

The cells of B, T, BT, and N groups were harvested at 72 h and then each washed
with PBS and fixed with 4% paraformaldehyde for 10 min, after which the slide
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Table 1. Transduction efficiency and cell pathological changes and optimal multiplicity of infection.
MOI
0

10

20

50

100

200

0%

62.50%

95%

100%

100%

100%

Transduction efficiency
B group
T group

0%

23.60%

68.60%

95.10%

99.70%

100%

BT group

0%

58.50%

95%

100%

100%

100%

pathological changes
B group

-

-

-

-

+

++

T group

-

-

-

-

+

++

BT group

-

-

-

-

++

++

- negative, + positive, ++, seriously.
doi:10.1371/journal.pone.0116061.t001

was blocked with 1% BSA for 30 min and incubated with primary antibody
(mouse anti–human BMP-2, 1:500; rabbit anti- human TGF-b3 1:40, Abcam,
England) for 120 min at 37 ˚C. After washing with PBS, the slide was incubated
with corresponding second antibody (goat anti-mouse IgG; goat anti-rabbit IgG
(Thermo Fisher, USA) diluted at a ratio of 1:200 for 60 min. Cell nuclei were
counterstained with DAPI (5 ng/ml) for 5 min. After washing with PBS the slide
was analyzed by fluorescence microscopy.
b. ELISA investigations

ELISA assays were performed to investigate the expression of BMP-2 or TGF-b3
in the culture supernatant. For the assay, flat-bottomed 96-well plates wells were
treated with 100 ml of cell culture supernatant and BMP-2 or TGF-b3 standards
and incubated at room temperature for 2 h. After three rinses with the washing
buffer, a biotin-conjugated BMP-2 or TGF-b3 monoclonal antibody was added to
each well at a concentration of 1 mg/ml in 100 ml and then incubated at room
temperature for 1 h. Following rinsing, avidin horse radish peroxidase (AV-HRP;
eBioscience) at a 1:500 dilution (100 ml/well) was added and the plates were
further incubated at room temperature for 30 min. Wells were again rinsed three
times with washing buffer and 100 ml of ABTS Substrate Solution (eBioscience)
was added to each well and incubated at room temperature for 30 min, and
optical densities were measured at 405 nm in a spectrophotometer (Molecular
Devices, Sunnydale, CA, USA).

Effects of Ad-BMP-2 or/and Ad-TGF-b3 transgene expression on
BMSCs
a. Quantitative RT-PCR Assay

Total ribonucleic acid (RNA) from the samples of BMSCs in the B, T, BT, and N
group at 3 d, 7 d, 14 d and 21 d were extracted with RNeasy mini kit (Qiagen,
Germany) following the manufacturer’s instructions. Complementary DNA was
prepared using SuperScript III first-strand synthesis system (Invitrogen, USA) and
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Table 2. Sequence of primers.
Gene

Upstream primer sequence (59-39)

downstream primer sequence (59-39)

BMP-2

ATCCTGAGCGAGTTCGAGTTG

ACCTGAAGTTCTGCAGAGGTG

TGF-b3

ACTTGCACCACCTTGGACTTC

GGTCATCACCGTTGGCTCA

b-actin

GTGCGGGACATCAAGGAGAA

ATGTCCACGTCGCACTTCAT

COL-2A

GTGCTCCCGGACCTCAAG

TCGCCAGATTTTCCAGGCTT

SOX9

GAGCAAGAATAAGCCGCACG

TTGCCCAGAGTCTTGCTGAG

aggrecan

CCCTCGTGGATACTACATTG

TGTCAGGAGACCCAGATGC

doi:10.1371/journal.pone.0116061.t002

the specificity of the PCR products was confirmed by agarose gel electrophoresis
(PCR primers are listed in Table 2). Expression of SOX9, COL-II and ACAN were
analyzed via iQ SYBRR green super mix (BIO-RAD) on MyiQ single color Real
Time polymerase chain reaction (RT-PCR) detection system (BIO-RAD). Relative
expression levels were calculated as the ratio to the average value of housekeeping
genes of b-Actin and relative gene expression was calculated according to the
22DCTDCT formula.
b. Immunochemical staining of collagen II

After 21 d, the cells in B, T, BT and N group were washed with PBS and fixed with
4% paraformaldehyde for 10 min, then the slide was blocked with 3% hydrogen
peroxide in methanol for 15 min and blocked with 5% BSA in PBS for 30 min.
Next, the sections were incubated for 1 h at room temperature with mouse
monoclonal anti-collagen type II primary antibodies at a dilution of 1:100 in 1%
BSA. After three PBS washes to remove unbound primary antibody, sections were
incubated with Streptavidin peroxidase-conjugated anti-mouse IgG secondary
antibody for 1 h at room temperature. Sections were then treated with
diaminobenzidine (DAB) for 10 min and observed under a light microscope.

The preparation and characterization of DBM
The DBM scaffold was constructed from the spongy bone of pig, as done
previously. In brief, the spongy bones were separated from the scapula and then
cut into pieces 7 mm diameter and 3 mm thick (Fig. 1A,B) before being soaked in
acetone for 48 h to remove fatty composition. Next, the samples were
demineralized 2 ˚C overnight incubation in a solution of 0.6 mol/L hydrochloric
acid; followed by washing with ddH2O, and then sterilized by ethylene oxide and
stored at 4 ˚C until use. The surface of the DBM was observed by Scanning
Electron Microscope (S-3400N, Hitachi, Japan). Diameters of the micropores and
porosity of DBM scaffolds was then determined via SEM imaging.

DBM combined with double genes transfected BMSCs
Third-passage BMSCs infected with Ad-BMP-2 + Ad-TGF-b3 (MOI520,50,
respectively) overnight were trypsinized and the density of cells was adjusted to
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Fig. 1. Gross appearance of DBM. The demineralized bone matrix scaffold looked like white sponge with
natural porous structure (A,B).
doi:10.1371/journal.pone.0116061.g001

26106 cells per milliliter with hyaluronic acid and DMEM/F-12 containing 10%
FBS and 1% penicillin/streptomycin(the ratio of hyaluronic acid and DMEM/F-12
was 1:4). 50 ml of cell suspension were added on every DBM(16105cells/DBM)
which was already prepared (soaked in PBS for 24 h) and then cultured in an
atmosphere of 5% CO2 and 95% humidity. Cells were allowed to attach to the
scaffolds for 4 h prior to the addition of fresh DMEM/F12 containing 10% FBS
and 1% antibiotics solution. The scaffolds were then further incubated at 37 ˚C
and 5% CO2 for 6 days. Adhesion properties, morphological characteristics, and
cellular distribution within each scaffold was analyzed via SEM (S-3400N, Hitachi,
Japan).

Surgery
To test the efficiency of the DBM treated with different growth factors, adult
diannan-small-ear pigs (n512, 8-month-old, weighing 12 kilograms on average)
were given a full-thickness defect and different scaffolds were placed within the
defect. In brief, the pigs were anethsitized by an intravenous injection of
pentobarbital and the knee joint was exposed via a medial parapatellar incision
and the patella was laterally displaced. With the knee maximally flexed, two fullthickness defects (7 mm in diameter and 3-4 mm in depth) were created in the
central weight bearing surface of the femur condyle using a dental drill (Fig. 2A).
The defects were washed with PBS to reduce bleeding prior to the different tissue
scaffolds being inserted into the defects in such a way that the composite surface
was flush with the articular surface (Fig. 2B). The patella was then repositioned,
and the capsule and skin were closed with a continuous suture. To minimize
postoperative infection, antibiotic penicillin was administered daily to each
subject for 5 days. To simulate natural activity, the animal subjects were housed in
conventional cages that allowed for unrestricted weight-bearing activity, while
researchers observed each subject for visible signs of pain, infection, and general
activity.
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Fig. 2. Implantation surgery. An osteochondral defect (diameter 56 mm; depth 54 mm) generated in the
central weight bearing surface of the femur condyle in knee(A). Prepared tissue-engineered scaffold were
inserted into the defect(B).
doi:10.1371/journal.pone.0116061.g002

Grouping and evaluation methodology
The 12 pigs used in this study (totally 24 knee joints and 48 full-thickness cartilage
defects) were randomly divided into 4 groups. The animals’ lateral femoral
condyle of right knee was repaired with DBM and BMSC infected with both Ad BMP-2 and Ad-TGF-b3(I group); The medial femoral condyle of right knee was
repaired with DBM and BMSCs without Ad-TGF-b3 and Ad-BMP-2(II group);
The medial femoral condyle of left knee was repaired with DBM(III group); The
medial femoral condyle was not repaired as blank control(IV group). The animals
were sacrificed at 2, 4, 8, 12 weeks postoperation (3 animals at each time point).
All procedures were approved by the appropriate institutional and governmental
review boards. Gross observation, H&E and safranin O staining, O’driscoll score
were used to assess the defect healing.

Statistical analysis
All data were analyzed via SPSS 11.5 (SPSS, inc., Chicago, USA). All values were
reported as mean ¡SD, with statistical significance determined via the Wilcoxon–
Mann Whitney test at a confidence interval level of 95% (P,0.05).

Results
Cell culture
BMSCs isolated from pigs were polygon and star shaped at passage 0 (Fig. 3A).
After passage 3, a relative homogeneous populations of fibroblast-like cells were
observed and displayed with a spindle structure consistent with previous reports
[9, 14] (Fig. 3B).
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Fig. 3. Characteristics of BMSCs. The trilateral and fibroblast-like cells were observed in primary cells 8
days after culture (A, Inverted phase contrast microscope6100). The primary BMSCs showed whirlpool
growth 14 days after cultured (B, Inverted phase contrast microscope 640).
doi:10.1371/journal.pone.0116061.g003

Multidirectional differentiation and flow cytometric analysis
There was lipid droplet in the cytoplasm of BMSCs which were positive for oil red
O staining (Fig. 4A). Osteogenic differentiation of BMSC was induced via an
osteogenic medium for 3 weeks. The induced cells formed Calcium nodules and
stained positively with Alizarin red (Fig. 4B). After chondrogenesis induction for
21 d, the BMSCs produced a cartilaginous matrix, which stained positively with
Alcian blue (Fig. 4C,D). Flow cytometric analysis demonstrated that the isolated
cells expressing the stem cell markers CD29, CD44 and negative for CD45. With
the increase of subculture, positive rate of CD29, CD44 increased accordingly.
There was no evident difference on CD45 between the P0, P1 and P2
BMSCs(Table 3).

Transfection efficiency
There were fluorescence expression in B and BT group 24 h to 48 h post
transduction. The fluorescence expression gradually strong with the increase of
MOI accordingly(Fig. 5A,B,C,D). Transduction efficiency of Ad-BMP-2 was
analyzed 48 h post transduction by determining the population of cells with GFP
expression within the total cell population(Fig. 5E,F). Almost all the BMSCs
express green fluorescence after transduced with Ad- BMP-2 48 h in
MOI520(Fig. 5G). Transduction efficiency of Ad-TGF-b3 was conformed by flow
cytometry(Fig. 5H). With the increase of MOI, there was cell pathological changes
in every group. The optimal multiplicity of infection was conformed to MOI520
(B group), 50(T group), 20 and 50 (BT group). The Transfection efficiency in B,
T, BT group was 95%,95.1%, 95%, respectively (MOI520,50,20 and 50) at 48 h
post transduction. There were no obviously cell pathological changes in B, T, BT
group with the MOI mentioned above.

PLOS ONE | DOI:10.1371/journal.pone.0116061 December 29, 2014
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Fig. 4. Multidirectional differentiation of BMSCs. Culture of BMSC under adipogenic conditions induced
drastic morphology changes including formation of cell aggregates and accumulation of lipid vacuoles in the
cytoplasm which positive for oil red O staining. (A, 6200). BMSCs were induced into osteogenetic cells 14
days after osteogenetic induction. Alizarin red staining showed there was calcium nodules formation (B,
640). There was pellet formation at the bottom of centrifuge tube after centrifugal. Glycosaminoglycan was
detected using alcian blue staining in cartilage pellets at Day 21 of culture(C, white arrow points to the pellet).
Presence of glycosaminoglycans was confirmed in histological sections of the pellet by alcian blue
staining(D).
doi:10.1371/journal.pone.0116061.g004

Gene expression
There was a positive red or green fluorescence staining in the BMSCs infected with
Ad-BMP-2 (red; B group) or Ad-TGF-b3 (green; T group) 72 h after transfection
(Fig. 6A, B). Both the red and the green fluorescence were detected in the BMSCs
infected with Ad-BMP-2 and Ad-TGF-b3 (BT group) (Fig. 6C). No positive red
or green fluorescence was detected in the cells infected with empty Ad (N group)
(Fig. 6D). PCR results showed that a band of Ad-BMP-2 at 310 bp (B group) and
Ad-TGF-b3 at 114 bp (T group). In the BT group, both 310 bp and 114 bp bands
were detected, and no band was detected in the control N group (Fig. 6E). ELISA
assay showed that the expression of BMP-2 and TGF-b3 increased gradually and
then peaked at 7 days following initial infection, and expression could still be
detected till 21 days post-transfection (Fig. 6F).

Table 3. The flow cytometry results of surface markers from BMSCs in different generation.
generation

CD29(+)

CD44(+)

CD45(2)

P0

73.10%

69.74%

99.68%

P1

99.44%m

99.96.

95.81%

P2

m

.

99.93%

99.49%

99.52

m

there were significant difference in the positive rate of CD29 compared with p0 group.
there were significant difference in the positive rate of CD44 compared with p0 group. There was no significant difference of the negative rate of CD45
among p0, p1, p2 groups.
.

doi:10.1371/journal.pone.0116061.t003
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Fig. 5. Adenoviral infection and the optimal multiplicity of infection. The fluorescence expression of BMSCs after transduced with Ad- BMP-2 48h in
MOI 10, 20, 50, 100 at 48 h(A,B,C,D),the fluorescence expression gradually strong with the increase of MOI. Transduction efficiency of Ad-BMP-2 was
analyzed 48 hours post transduction by determining the population of cells with GFP expression within the total cell population(E,F). almost all the BMSCs
express green fluorescence after transduced with Ad- BMP-2 48 h in MOI520(G). Transduction efficiency of Ad-TGF-b3 was conformed by flow cytometry,
the Transduction efficiency was 95.1% 48 h post transduction in MOI550(H).
doi:10.1371/journal.pone.0116061.g005

Effect of Ad-BMP-2 or/and Ad-TGF-b3-induced BMSCs
chondrogenesis
a. Specific gene expression in chondrogenic differentiation

ELISA assays showed that the expression of both BMP-2 and TGF-b3 decreased
respectively at 14 d and 21 d, as compared with the levels 7 d post-transfection in
the three treated group. The expression of SOX-9, COL-2A, and ACAN were upregulated with the increased of culture time in each of the three treated groups.
Notably, the expression of SOX-9, COL-2A and ACAN were significantly
increased in BT group as compared with either of the individual treated groups
(Fig. 7A–C). Similarly, the BT group exhibited markedly more potent induction
of chondrocytic gene expression than either the treated BMP-2 or TGF-b3 groups
alone, while the negative control group showed either negligible or no expression
at any detectable level.
b. Immunohistochemical staining of type II collagen

Immunohistochemical staining indicated that the cells were positive for type II
collagen in B, T, and BT groups at 21 d after culture. The cell of BT group
appeared to have acquired a strong type II collagen staining as compared either
the those infected cells in the B or T groups. The uninfected cells (N group)
remainined negative for type II collagen staining throughout the experiment
(Fig. 8A–D).
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Fig. 6. Image of immunofluorescence, PCR electrophoresis and ELISA detection after transfection.
Image of immunofluorescence performed 72 hours after transfection of BMSCs. There was a positive red(A)
or green(B) fluorescence staining in the BMSCs in B group or T group 72 h after transfection. Both the red and
the green fluorescence were detected in the BT group (C). No positive red or green fluorescence was
detected in the N group (D). PCR results showed a band at 310 bp (B group) and at 114 bp was detected in B
and T group, respectively. In the BT group, both 310 bp and 114 bp bands were detected, and no band was
detected in the control N group (E). ELISA assay showed that the expression of BMP-2 or TGF-b3 increased
gradually and then peaked at 7 days following initial infection, and expression could still be detected till 21
days post-transfection (F,G).
doi:10.1371/journal.pone.0116061.g006

Fig. 7. The expression of SOX-9, COL-2A, ACAN in B, T, BT group at 1W,2W,3W after transfection. Total
RNA from the samples of BMSCs in the B, T, BT, and N group at 7 d, 14 d and 21 d were extracted with
RNeasy mini kit. Complementary DNA was prepared using SuperScript III first-strand synthesis system.
Expression of SOX9, COL-II and ACAN were analyzed via iQ SYBRR green super mix on MyiQ single color
Real Time polymerase chain reaction (RT-PCR) detection system. The relative expression expression of
SOX-9, COL-2A and ACAN were significantly increased in BT group as compared with either of the individual
treated groups (*P,0.05, * *P,0.01).
doi:10.1371/journal.pone.0116061.g007
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Fig. 8. Immunohistochemical image of COL-II 21 days after transfection. Type II collagen expression was detected using a mouse monoclonal antibody
(1:200; Abcam, England) and a horseradish peroxidase-conjugated anti-mouse antibody (1:50; Dako, Denmark), followed by colour development with
diaminobenzidine tetrahydrochloride (DAB, Dako). The cell of BT group(C) acquired a strong type II collagen staining compared with B group (A) and T
group (B). The N group (D) were negative for type II collagen staining.
doi:10.1371/journal.pone.0116061.g008

The electron microscope micrograph of DBM
SEM revealed a highly fibrous and porous structure of the DBM, with an average
pore size of 119.42¡6.46 mm, which should theoretically permit BMSCs
migration and growth, and facilitate the diffusion of nutrients into the matrix
(Fig. 9A). SEM was also performed on the DBMs after culturing with BMSCs in
order to observe cell attachment, growth and spatial distribution of BMSCs on the
DBM scaffolds. Images showed that BMSCs infected with Ad-BMP-2 and AdTGF-b3 begin to attach to DBM scaffolds 2 day after seeding (Fig. 9B). BMSCs
were densely packed and formed connections between the DBM and were well
dispersed throughout the porous surface 6 days after cell seeding (Fig. 9C). By day
7, most of the DBM pores were deposited with abundant cells (Fig. 9D).
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Fig. 9. SEM image of DBM and the adhesion and morphology of induced BMSCs cultured on DBM. SEM showed DBM had natural netlike structure
with pores interconnected(A). A large number of cells was growing and covering the surface of DBM 2days after incubation(B). SEM showed the number of
cells significantly increased(blue arrow), the spindled cell growing on the surface and the interior of DBM(red arrow)(C,D).
doi:10.1371/journal.pone.0116061.g009

Evaluations of cartilage defect repaired
a. Gross Evaluations

In terms of the gross appearance of filling amounts in defective areas, the I group
seemed to be superior to other tested groups, followed by the II group and then
the III group, with the negative control IV group faring the worst. At 12 weeks
post-operation, the full-thickness cartilage lesions had healed in all cases among
the I group, with the contour of the femur being nearly entirely repaired and both
the color and quality of repaired tissue being similar to the surrounding healthy
cartilage. In both the II and III groups, the defects did not appear to fully heal and
remained irregular, with the contour of the femur surrounding the defects
remaining visibly discernible. By contrast, the negative control group were failed
to heal and repair, and were filled with fibrous tissue or granular tissues(Fig.10).
Taken collectively, these visual inspect result showed that the DBM combining
BMSCs cell infected with Ad-BMP-2 and Ad-TGF-b3 more successfully repaired
the full-thickness cartilage defects we administered to the animal models as
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Fig. 10. The gross observation of group I, II, III, IV at operation, 4W, 8W and 12W after operation. At 12
weeks post-operation, the full-thickness cartilage lesions had healed in I group, with the contour of the femur
being nearly entirely repaired and both the color and quality of repaired tissue being similar to the surrounding
healthy cartilage. In both the II and III groups, the defects did not appear to fully heal and remained irregular,
with the contour of the femur surrounding the defects remaining visibly discernible. There was retained a
severe degeneration, in IV group.
doi:10.1371/journal.pone.0116061.g010

compared with the other tested groups, with the negative control group showing
no signs of effective repair.
b. Histological evaluation

Results of the H&E and safranin O staining showed that the defects were mainly
composed of DBM, and the boundaries to adjacent cartilage were clear in each
group at 2 weeks after operation (data not shown). It appears that the DBM
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scaffolds were gradually absorbed over time, and by 8 weeks post-operation they
were completely absorbed in all groups. In the defect area, chondrocytes and
cartilage lacunas were largely increased, and the repaired tissue were main hyaline
cartilage with safranin O positive stain in I group. At 12 weeks post-operation, the
repaired tissue was largely hyaline cartilage that stained positively with safranin O
staining, as compared with other three groups (Fig. 11).
c. O’driscoll score

The repair effectiveness of the defect cartilage in all four groups was also evaluated
using the O’driscoll score. Results of the O’driscoll scores at 12W postoperation
were as follows: 15.65¡0.61 (BT group), 11.33¡1.08 (T group), 9.13¡0.85 (B
group) and4.38¡1.35 (N group) (Fig. 12). The scores of BT group were
significantly higher than both control and non-treatment group scores, there was
significant difference among the groups (*P,0.05, * *P,0.01).

Discussion
Given the difficulty in repairing tissues that have naturally low capacities for selfregeneration, tissue engineering has emerged as a new method in which a
combination of cells, scaffold, and bioactive agents are used to fabricate functional
new tissues that can repair damaged cartilage that has traditionally resisted
effective treatment [20–22]. In this study, we generated a new type of tissue
engineering cartilage using a genetic enhancement technique in which a DBM was
cultured with BMSCs infected with Ad-BMP-2 and Ad-TGF-b3. In vitro, BMSCs
treated with Ad-BMP-2 and Ad- TGF-b3 (BT group) acquired strong type II
collagen staining as compared with both the groups infected with either Ad-BMP2 (B group) or Ad-TGF-b3 (T group) alone (Fig. 8). Similarly, the respective
expression of COL-2A, ACAN, SOX9 in the BT group was markedly higher than
either the B group or T group (Fig. 7). In vivo, we found that the defected
cartilage in our pig models was repaired by hyaline cartilage that stained positively
with Safranin O in the I group (Fig. 10); A finding matched by gross observation
and histology that showed in I group it was difficult to identify the border
between the repaired cartilage in the defected areas and the adjacent normal,
healthy cartilage (Fig. 9, Fig. 10). Compared with this I group, the II, III groups
and the negative control group either failed to adequately fill the defected cavities
or formed fibrous tissue mainly composed of fibrous cartilage.
In tissue engineering therapeutics, BMSCs are commonly employed for
cartilage regeneration since they are multi-potent cells that can differentiate into
many different cell types when cultured in particular environment. A growing
number of studies have demonstrated that growth factors have specific effects on
chondrogenesis. BMP-2 has been proven to enhance the expression of
chondrogenic matrix components, such as type II collagen and aggrecan in vitro
[23–25]. The precartilaginous cells in condensations do not differentiate into
chondrocytes in the absence of BMP signaling [26, 27]. TGF-b3 as key cell
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Fig. 11. The imagine of H&E and safranin O staining in group I, II, III, IV at 8W and 12W after operation. It
appears that the DBM scaffolds were gradually absorbed over time, and by 8 weeks post-operation they were
completely absorbed in all groups. In the defect area, chondrocytes and cartilage lacunas were largely
increased, and the repaired tissue were main hyaline cartilage with safranin O positive stain in I group. At 12
weeks post-operation, the repaired tissue was largely hyaline cartilage that stained positively with safranin O
staining, as compared with other three groups.
doi:10.1371/journal.pone.0116061.g011

Fig. 12. The The O’driscoll score of group I, II, III, IV at 8W and 12W after operation. At 12W after
implantation, I group scores were significantly higher than both control and non-treatment group scores
(*P,0.05, * *P,0.01).
doi:10.1371/journal.pone.0116061.g012
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adjustment control factor involved in the cell aggregates of appreciation,
differentiation and maturation of each order section [28, 29], it has been treated as
an effective induced factor, prompting seed cells to the cartilage differentiation in
the cartilage tissue engineering. Recent studies have further demonstrated that
both growth factors in combination induced significantly higher expression of
cartilage-specific genes and elevated release of cartilage-specific extracellular
matrix proteins [30, 31]. As evidenced in our experiments, there were acquired
strong type II collagen staining in cells infected with Ad-BMP-2 and Ad-TGF-b3
(BT group) compared with B group and T group, indicating that the combination
of Ad-BMP-2 and Ad-TGF-b3 is likely to be superior to the standard
differentiation method using either Ad-TGF-b3 or Ad-BMP-2 alone for BMSC
chondrogenesis(Fig. 8).
In tissue engineering therapeutics, scaffolds play a pivotal role because they
supported cell attachment, proliferation, and differentiation; To date, numerous
types of scaffolds—both natural and synthetic—have been proposed for use in
cartilage tissue engineering [21, 32]. The natural tissues scaffolds are not always
able to used successfully as often they can be damaged or must be removed. As to
synthetic polymers scaffold, although they have been used successfully, the fact
that they could only provide a scaffold for cartilage in-growth rather than
possessing tissue-derived substances such as growth factors or cells precludes them
from being ideal bone substitutes [33].
An alternative that overcomes this limitation is the use of DBM. As an allogrous
tissue derived from native osseous tissue, its close relation in structure and
function with autologous bone allows it to contain bone morphogenic proteins
(BMPs) and matrix proteins [34]. BMPs are potent cartilage-inducing factor,
which in vitro have been found capable of generating cartilage by inducing
differentiation of mesenchymal cells into chondrocytes [35]. Moreover, while
matrix proteins, such as different collagens, provide a cartilage induced matrix
that can enable BMSCs cell adhesion. In our experiment, we also demonstrated
that DBM has highly fibrous and porous structure, with an average pore size of
119.42¡6.46 mm and average porosity of 60.19¡6.10%, which should theoretically be a suitable size for allowing both cell adhesion and growth, this porous
structure should assist in the penetration of nutrients into the matrix, which
affects cells proliferation. In our experiment in vitro, SEM images showed that the
Ad-BMP-2 and Ad-TGF-b3 infected BMSCs adhered and propagated well in
DBM, the cells formed connections between the DBM and were well dispersed
throughout the porous surface and inner 6 days after cell seeding. In our animal
models, the macroscopical and histological evidence shows that when these DBM
scaffolds combined with BMSCs were implanted into a defect in the femoral
condyle, the cartilage repair worked most effectively when the BMSCs were
infected with Ad-BMP-2 and Ad-TGF-b3. This is not an unsurprising finding
given that in cartilage tissue engineering, growth factors are important for
regulating cell proliferation, differentiation, maturation.
The success of cartilage formation depends largely on the means to achieve
stable, sustained and effective growth factor expression, but the clinical utility of
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those protein is limited due to their short half-lives and instability in vivo. Gene
therapy may be viewed as a drug delivery system that is able to deliver an
essentially pure agent to a specific location in a delayed-release fashion [36], it was
a good alternative to direct protein delivery. Adenoviruses are the most widely
used gene therapy vector due to these viruses are able to infect both dividing and
non-dividing cells and can be produced at high titers, as well as to propagate
without integrating into the host genome [37]. The present study involved the use
of gene transfer as a means to provide sustained delivery of chondrogenic proteins
to primary BMSCs. Gene-induced chondrogenesis of BMSCs using multiple genes
that act synergistically may enable the administration of reduced viral doses in
vivo and could be of considerable benefit for the development of cell-based
therapies for cartilage repair. In our experiment, the cells infected with Ad-BMP-2
and Ad-TGF-b3 at MOI520, MOI550 respectively have no obvious pathological
change at 24 hours and 48 hours under optical microscope, adenoviruses vector
had no obvious effect on cell growth and proliferation infected with suitable MOI.
The Immunofluorescence staining, PCR and ELISA showed that the Ad-BMP-2
and Ad-TGF-b3 could be transfected and expressed effectively in BMSCs, realtime PCR showed that the expression of TGF-b3 and BMP-2 genes sustainable for
3 weeks, which is long enough to induce BMSCs to chondrocytes.
Taken together, these results strongly suggest that a combination of Ad-BMP-2
and Ad-TGF-b3 gene transfer can more effectively induce BMSCs differentiation
into cartilage in vitro; The DBM scaffolds derived from spongy bone tissue
combined with BMSCs can repair cartilage defects in vivo, but works most
effectively when both Ad-BMP-2 and Ad-TGF-b3 are present. The above results
suggest this combination is far more suitable for clinical treatments of articular
cartilage damage.
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